# Effects of Varenicline on Brain Activity During Nicotine Abstinence

> **NCT00602927** · NA · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 38 (actual)

## Conditions studied

- Nicotine Dependence

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00602927
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2011-05-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00602927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00602927, "Effects of Varenicline on Brain Activity During Nicotine Abstinence". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00602927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*